Correlation Between Sana Biotechnology and Pasithea Therapeutics
Can any of the company-specific risk be diversified away by investing in both Sana Biotechnology and Pasithea Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sana Biotechnology and Pasithea Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sana Biotechnology and Pasithea Therapeutics Corp, you can compare the effects of market volatilities on Sana Biotechnology and Pasithea Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sana Biotechnology with a short position of Pasithea Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sana Biotechnology and Pasithea Therapeutics.
Diversification Opportunities for Sana Biotechnology and Pasithea Therapeutics
-0.53 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Sana and Pasithea is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Sana Biotechnology and Pasithea Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pasithea Therapeutics and Sana Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sana Biotechnology are associated (or correlated) with Pasithea Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pasithea Therapeutics has no effect on the direction of Sana Biotechnology i.e., Sana Biotechnology and Pasithea Therapeutics go up and down completely randomly.
Pair Corralation between Sana Biotechnology and Pasithea Therapeutics
Given the investment horizon of 90 days Sana Biotechnology is expected to under-perform the Pasithea Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Sana Biotechnology is 4.64 times less risky than Pasithea Therapeutics. The stock trades about -0.24 of its potential returns per unit of risk. The Pasithea Therapeutics Corp is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest 2.03 in Pasithea Therapeutics Corp on September 24, 2024 and sell it today you would earn a total of 0.27 from holding Pasithea Therapeutics Corp or generate 13.3% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 40.0% |
Values | Daily Returns |
Sana Biotechnology vs. Pasithea Therapeutics Corp
Performance |
Timeline |
Sana Biotechnology |
Pasithea Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Good
Sana Biotechnology and Pasithea Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Sana Biotechnology and Pasithea Therapeutics
The main advantage of trading using opposite Sana Biotechnology and Pasithea Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sana Biotechnology position performs unexpectedly, Pasithea Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pasithea Therapeutics will offset losses from the drop in Pasithea Therapeutics' long position.Sana Biotechnology vs. Olema Pharmaceuticals | Sana Biotechnology vs. Cullinan Oncology LLC | Sana Biotechnology vs. Zentalis Pharmaceuticals Llc | Sana Biotechnology vs. X4 Pharmaceuticals |
Pasithea Therapeutics vs. Fate Therapeutics | Pasithea Therapeutics vs. Sana Biotechnology | Pasithea Therapeutics vs. Caribou Biosciences | Pasithea Therapeutics vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |